Cardionomic Overview
- Founded
- 2013

- Status
- Private
- Employees
- 14

- Latest Deal Type
- Later Stage VC
- Latest Deal Amount
- $5M

- Investors
- 4
Cardionomic General Information
Description
Developer of a cardiac therapy intended to treat acute decompensated heart failure. The company's treatments address the condition's root cause of reduced contractility using neuromodulation to increase contractility, improve cardiac output, and increase renal flow or end-organ perfusion, enabling healthcare practitioners to decrease negative hormonal signaling and improve in-hospital morbidity and mortality.
Contact Information
- 601 Campus Drive
- Suite 12
- New Brighton, MN 55112
- United States
Cardionomic Timeline
Cardionomic Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
5. Later Stage VC | 04-Oct-2021 | $5M | 000.00 | Completed | Clinical Trials - Phase 2 | |
4. Later Stage VC (Series A2) | 21-Feb-2020 | 000.00 | 000.00 | 000.00 | Completed | Clinical Trials - Phase 2 |
3. Later Stage VC (Series A1) | 30-Apr-2018 | 000 | 000.00 | 000.00 | Completed | Clinical Trials - Phase 2 |
2. Early Stage VC (Series A) | 02-Oct-2015 | $20M | $22.4M | Completed | Clinical Trials - Phase 1 | |
1. Early Stage VC (Series A) | 01-Apr-2014 | $2.35M | $2.35M | Completed | Clinical Trials - Phase 1 |
Cardionomic Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series A2 | 00,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Series A2 (NV) | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 00 |
Series A1 (NV) | 5,439,215 | $0.001000 | $0.12 | $1.47 | $1.47 | 1x | $1.47 | 0% |
Series A1 | 18,786,541 | $0.001000 | $0.13 | $1.63 | $1.63 | 1x | $1.63 | 46.63% |
Cardionomic Patents
Cardionomic Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
CA-3137307-A1 | Systems and methods for denoising physiological signals during electrical neuromodulation | Pending | 06-May-2019 | 0000000000 | |
AU-2020269601-A1 | Systems and methods for denoising physiological signals during electrical neuromodulation | Pending | 06-May-2019 | 0000000000 | |
EP-3836859-A1 | Systems and methods for affecting cardiac contractility and/or relaxation | Pending | 13-Aug-2018 | 0000000000 | |
AU-2019320750-A1 | Systems and methods for affecting cardiac contractility and/or relaxation | Pending | 13-Aug-2018 | 00000000000 | |
CA-3107959-A1 | Systems and methods for affecting cardiac contractility and/or relaxation | Pending | 13-Aug-2018 | A61B18/1492 |
Cardionomic Executive Team (4)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Steve Goedeke | Founder, Chief Executive Officer, President & Board Member | ||
Todd Kerkow | Chief Technology Officer | ||
Michelle Kennefick | Vice President of Clinical Research |
Cardionomic Board Members (16)
Name | Representing | Role | Since |
---|---|---|---|
Ali Behbahani MD | New Enterprise Associates | Board Member | 000 0000 |
Andrew Senn | Self | Board Member | 000 0000 |
Anthony Borowicz | Integer | Board Member | 000 0000 |
Brian Farley | Self | Board Member | 000 0000 |
Jon Friedland | Self | Board Member | 000 0000 |
Cardionomic Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialCardionomic Investors (4)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Cleveland Clinic Ventures | Corporate Venture Capital | Minority | 000 0000 | 000000 0 | |
Ascension Ventures | Corporate Venture Capital | Minority | 000 0000 | 000000 0 | |
Integer | Corporation | Minority | 000 0000 | 000000 0 | |
New Enterprise Associates | Venture Capital | Minority | 000 0000 | 000000 0 |